ZVRA
Zevra Therapeutics Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$592.92M
P/E Ratio
4.99
EPS
$2.01
Beta
0.88
52W High
$13.16
52W Low
$7.16
50-Day MA
$10.05
200-Day MA
$9.40
Dividend Yield
—
Profit Margin
101.60%
Forward P/E
9.51
PEG Ratio
10.67
About Zevra Therapeutics Inc.
Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company is headquartered in Celebration, Florida.
Fundamentals
| Revenue (TTM) | $122.29M |
| Gross Profit (TTM) | $105.25M |
| EBITDA | $12.73M |
| Operating Margin | 24.40% |
| Return on Equity | 100.60% |
| Return on Assets | 2.76% |
| Revenue/Share (TTM) | $2.17 |
| Book Value | $2.72 |
| Price-to-Book | 2.88 |
| Price-to-Sales (TTM) | 4.85 |
| EV/Revenue | 3.215 |
| EV/EBITDA | 2.73 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 77.50% |
| Shares Outstanding | $59.12M |
| Float | $54.96M |
| % Insiders | 1.40% |
| % Institutions | 70.62% |
Historical Volatility
HV 10-Day
57.87%
HV 20-Day
56.50%
HV 30-Day
52.00%
HV 60-Day
61.03%
HV Rank
41.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($23.00 target)
2
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026